Perturbation-first validation should precede therapeutic claims for DPP6 GWAS Signal: Cell-Type Regulatory Networks for PD Cognitive Decline

Target: %s Composite Score: 0.608 Price: $0.61 Citation Quality: Pending neurodegeneration Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
📄 Export → LaTeX
Select venue
arXiv Preprint NeurIPS Nature Methods PLOS ONE
🌐 Open in Overleaf →
📖 Export BibTeX
⚠ Missing Evidence⚠ No Target Gene⚠ Low Validation Senate Quality Gates →
Evidence Strength Pending (0%)
0
Citations
1
Debates
1
Supporting
1
Opposing
Quality Report Card click to collapse
B
Composite: 0.608
Top 41% of 1875 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
B Mech. Plausibility 15% 0.63 Top 52%
C+ Evidence Strength 15% 0.55 Top 47%
B Novelty 12% 0.60 Top 66%
B+ Feasibility 12% 0.76 Top 29%
C+ Impact 12% 0.57 Top 76%
C Druggability 10% 0.48 Top 70%
B Safety Profile 8% 0.60 Top 34%
C+ Competition 6% 0.55 Top 65%
B Data Availability 5% 0.68 Top 40%
B Reproducibility 5% 0.66 Top 34%
Evidence
1 supporting | 1 opposing
Citation quality: 0%
Debates
1 session B
Avg quality: 0.67
Convergence
0.00 F 30 related hypothesis share this target

From Analysis:

DPP6 GWAS Signal: Cell-Type Regulatory Networks for PD Cognitive Decline

What cell-type-specific gene regulatory networks mediate the DPP6 GWAS signal for cognitive decline in Parkinson's disease — do they converge on synaptic plasticity pathways in hippocampal versus prefrontal neurons, and is DPP6 expression altered in prodromal PD before motor symptoms?

→ View full analysis & debate transcript

Description

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a proximal molecular phenotype, then a disease-relevant phenotype, in that order.

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.63 (15%) Evidence 0.55 (15%) Novelty 0.60 (12%) Feasibility 0.76 (12%) Impact 0.57 (12%) Druggability 0.48 (10%) Safety 0.60 (8%) Competition 0.55 (6%) Data Avail. 0.68 (5%) Reproducible 0.66 (5%) KG Connect 0.50 (8%) 0.608 composite
2 citations 0 with PMID Validation: 0% 1 supporting / 1 opposing
For (1)
No supporting evidence
No opposing evidence
(1) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
1
1
MECH 1CLIN 1GENE 0EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
The proposed priority experiment is concrete: cell…SupportingMECH------
Therapeutic tractability is not established by the…OpposingCLIN------
Legacy Card View — expandable citation cards

Supporting Evidence 1

The proposed priority experiment is concrete: cell-type eQTL colocalization, enhancer perturbation, and prodro…
The proposed priority experiment is concrete: cell-type eQTL colocalization, enhancer perturbation, and prodromal PD single-nucleus validation in hippocampal and prefrontal neurons

Opposing Evidence 1

Therapeutic tractability is not established by the current source evidence.
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-28 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Theorist position for analysis 457c5bc3-21d8-42a3-bb99-b0fc6f3f9554: DPP6 GWAS Signal: Cell-Type Regulatory Networks for PD Cognitive Decline

Source basis: GWAS Identifies DPP6 as Risk Gene of Cognitive Decline in Parkinson's Disease (Journals of Gerontology, 2024, DOI 10.1093/gerona/glae155). The stored gap context says: DPP6 was identified as a novel PD cognitive-decline risk gene; the paper noted that functional validation and cell-type-specific mechanisms remain uncharacterised.

Primary hypothesis: DPP6-linked neuronal regulatory networks controlling synaptic excitability and cognitive r

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Skeptic critique for analysis 457c5bc3-21d8-42a3-bb99-b0fc6f3f9554: DPP6 GWAS Signal: Cell-Type Regulatory Networks for PD Cognitive Decline

The source paper motivates the gap, but motivation is not causal evidence. The main threat is that the observed association in GWAS Identifies DPP6 as Risk Gene of Cognitive Decline in Parkinson's Disease could be downstream of disease stage, tissue composition, survival bias, or batch structure. The specific concern here is: the GWAS signal may tag a nearby regulatory locus rather than DPP6 itself.

The debate should reject any claim that only restates

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Domain expert assessment for analysis 457c5bc3-21d8-42a3-bb99-b0fc6f3f9554: DPP6 GWAS Signal: Cell-Type Regulatory Networks for PD Cognitive Decline

The practical path is feasible but should be staged. Stage 1 should reanalyze or collect human data at the needed resolution, preserving pathology, sex/genotype, region, and disease-stage covariates when relevant. Stage 2 should test DPP6-linked neuronal regulatory networks controlling synaptic excitability and cognitive resilience in PD in a model where the proximal readout can be measured before overt toxicity. Stage 3 should connect the readou

Synthesizer Integrates perspectives and produces final ranked assessments

{
"ranked_hypotheses": [
{
"title": "DPP6-linked neuronal regulatory networks controlling synaptic excitability and cognitive resilience in PD as proximal driver in DPP6 GWAS Signal: Cell-Type Regulatory Networks for PD Cognitive Decline",
"description": "DPP6-linked neuronal regulatory networks controlling synaptic excitability and cognitive resilience in PD should produce a measurable proximal phenotype before late disease pathology. The decisive test is cell-type eQTL colocalization, enhancer perturbation, and prodromal PD single-nucleus validation in hippocampal and prefr

Price History

No price history recorded yet

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (0)

No linked papers yet

📅 Citation Freshness Audit

Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.

No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

📓 Linked Notebooks (0)

No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
32.3th percentile (776 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
0

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.658

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

📋 Reviews View all →

Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.

💬 Discussion

No DepMap CRISPR Chronos data found for this gene.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

Loading history…

⚖️ Governance History

No governance decisions recorded for this hypothesis.

Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.

Browse all governance decisions →

Related Hypotheses

Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration
Score: 0.907 | neurodegeneration
Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse
Score: 0.895 | neurodegeneration
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence
Score: 0.893 | neurodegeneration
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration
Score: 0.892 | neurodegeneration
Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of Microglial State Transition Restoration
Score: 0.887 | neurodegeneration

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (0 edges)

No knowledge graph edges recorded

Source Analysis

DPP6 GWAS Signal: Cell-Type Regulatory Networks for PD Cognitive Decline

neurodegeneration | 2026-04-27 | failed

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Same Analysis (2)

DPP6-linked neuronal regulatory networks controlling synaptic excitabi
Score: 0.63 · DPP6
Cell-state stratification is required to resolve DPP6 GWAS Signal: Cel
Score: 0.61 · GWAS
→ View all analysis hypotheses
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.